12:00 AM
Feb 07, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Angiostatin: Began Phase I trial

EntreMed Inc. (ENMD), Rockville, Md.
Product: Angiostatin
Business: Cancer
Therapeutic category: Angiogenesis
Target: Endothelial...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >